These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11222565)

  • 21. Establishment of genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis.
    Ito JI; Harrison HR; Alexander ER; Billings LJ
    J Infect Dis; 1984 Oct; 150(4):577-82. PubMed ID: 6541671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice.
    Pal S; Peterson EM; de la Maza LM
    Immunology; 2003 Nov; 110(3):368-75. PubMed ID: 14632665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlamydial infection in a population of Ethiopian women attending obstetric, gynaecological and mother and child health clinics.
    Duncan ME; Jamil Y; Tibaux G; Pelzer A; Mehari L; Darougar S
    Cent Afr J Med; 1996 Jan; 42(1):1-14. PubMed ID: 8868379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is it time to switch to doxycycline from azithromycin for treating genital chlamydial infections in women? Modelling the impact of autoinoculation from the gastrointestinal tract to the genital tract.
    Craig AP; Kong FY; Yeruva L; Hocking JS; Rank RG; Wilson DP; Donovan B
    BMC Infect Dis; 2015 Apr; 15():200. PubMed ID: 25925662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
    Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
    DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines for Chlamydia infections of the female genital tract.
    Hafner LM; McNeilly C
    Future Microbiol; 2008 Feb; 3(1):67-77. PubMed ID: 18230035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection.
    Su H; Morrison R; Messer R; Whitmire W; Hughes S; Caldwell HD
    J Infect Dis; 1999 Oct; 180(4):1252-8. PubMed ID: 10479155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India.
    Bhengraj AR; Vardhan H; Srivastava P; Salhan S; Mittal A
    Chemotherapy; 2010; 56(5):371-7. PubMed ID: 20938174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel guinea pig model of Chlamydia trachomatis genital tract infection.
    de Jonge MI; Keizer SA; El Moussaoui HM; van Dorsten L; Azzawi R; van Zuilekom HI; Peters PP; van Opzeeland FJ; van Dijk L; Nieuwland R; Roosenboom-Theunissen HW; Vrijenhoek MP; Debyser I; Verweij PJ; van Duijnhoven WG; van den Bosch JF; Nuijten PJ
    Vaccine; 2011 Aug; 29(35):5994-6001. PubMed ID: 21718744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.
    Ito JI; Lyons JM; Airo-Brown LP
    Infect Immun; 1990 Jun; 58(6):2021-3. PubMed ID: 2341189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.
    Vicetti Miguel RD; Quispe Calla NE; Pavelko SD; Cherpes TL
    PLoS One; 2016; 11(9):e0162445. PubMed ID: 27606424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing the risk of Chlamydia trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals.
    Lyons JM; Ito JI
    Clin Infect Dis; 1995 Oct; 21 Suppl 2():S174-7. PubMed ID: 8845448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.
    Manavi K; Hettiarachchi N; Hodson J
    Int J STD AIDS; 2016 Dec; 27(14):1303-1308. PubMed ID: 26511655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interpretation of Chlamydia trachomatis antibody response in chlamydial oculogenital infection.
    Patel HC; Goh BT; Viswalingam ND; Treharne JD
    Genitourin Med; 1995 Apr; 71(2):94-7. PubMed ID: 7744422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydial genital tract infection.
    Su H; Caldwell HD
    Infect Immun; 1998 Mar; 66(3):1258-60. PubMed ID: 9488423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis.
    Tuffrey M; Falder P; Taylor-Robinson D
    Br J Exp Pathol; 1982 Oct; 63(5):539-46. PubMed ID: 7171478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia trachomatis-induced salpingitis in mice.
    Swenson CE; Donegan E; Schachter J
    J Infect Dis; 1983 Dec; 148(6):1101-7. PubMed ID: 6655289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of an immune modulator in experimental Chlamydia trachomatis infection of the female genital tract.
    Lyons JM; Ito JI; Morré SA
    Infect Dis Obstet Gynecol; 2006; 2006():61265. PubMed ID: 17093354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.
    Cheng W; Shivshankar P; Li Z; Chen L; Yeh IT; Zhong G
    Infect Immun; 2008 Feb; 76(2):515-22. PubMed ID: 18025098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of matrix metalloproteinase-7 in the modulation of a Chlamydia trachomatis infection.
    Pal S; Schmidt AP; Peterson EM; Wilson CL; de la Maza LM
    Immunology; 2006 Feb; 117(2):213-9. PubMed ID: 16423057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.